Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease

BACKGROUND: SARS-CoV-2 (COVID-19) disease causes significant morbidity and mortality through increased inflammation and thrombosis. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are states of chronic inflammation and indicate advanced metabolic disease. OBJECTIVE:...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Surg Obes Relat Dis
Main Authors: Tignanelli, Christopher J., Bramante, Carolyn T., Dutta, Nirjhar, Tamariz, Leonardo, Usher, Michael G., Ikramuddin, Sayeed
Formato: Artigo
Idioma:Inglês
Publicado: Published by Elsevier Inc. on behalf of American Society for Bariatric Surgery. 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238640/
https://ncbi.nlm.nih.gov/pubmed/34326020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.soard.2021.05.029
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares